Journal of the American Medical Association (JAMA)

Edit Your Profile

Journal of the American Medical Association (JAMA) Journal

publication venue for

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. 2022

Electronic International Standard Serial Number (EISSN)

1538-3598